Evolution of the bone mass of hypertense menopausal women in treatment with fosinopril;Evolución de la densidad ósea de mujeres menopáusicas hipertensas en tratamiento con fosinopril

Medicina Clinica

Volumn 127, Issue 18, 2006, Pages 692-694

  García Testal, Alicia ^a   Monzó, Ana ^a   Rabanaque, Gloria ^b   González, Antonio ^c   Romeu, Alberto ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Centro de Salud Nazaret   (Spain)

^c HOSPITAL DE SAGUNTO   (Spain)

Author keywords

Angiotensin; Hypertension; Osteoporosis

Indexed keywords

FOSINOPRIL;

ARTICLE; BONE DENSITY; BONE MASS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FEMUR NECK; HUMAN; HYPERTENSION; LUMBAR SPINE; MENOPAUSE; OSTEOLYSIS; OSTEOPOROSIS; PROSPECTIVE STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 33845989076     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095095     Document Type: Article

References (10)

1. Honorato J, Escolar M, García E. Relaciones hipertensión arterial esencial-osteoporosis: impacto del tratamiento antihipertensivo sobre el metabolismo extracelular del calcio. Rev Clin Esp. 1999:199:523-9.
2. García-Testal A, Monzó A, Rabanaque G, González A, Romeo A. Relación entre hipertensión arterial y osteoporosis en la menopausia. Hipertension. 2006;23:41-8.
3. Hagiwara H, Hiruma Y, Inoue A, Yamaguchi A, Hirose S. Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol. 1998;156:543-50.
4. Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA. 2003;289:2534-44. Disponible en: http://jama.amaassn.org/cgi/content/full/289. 19.2560v1
5. Ferrer J, Tovar I, Tortosa J, Martinez P. Marcadores bioqulmicos de remodelado en el estudio de la masa ósea en la mujer con menopausia reciente sin osteoporosis. Med Clin (Barc). 2005; 124:241-9.
6. Barr M, Cohen MM. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection. Teratology. 1991;44:485-95.
7. Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of beta-blockers and risk of fractures. JAMA. 2004;292:1326-32.
8. Pérez-Castrillón JL, Silva J, Justo I, Sanz A, Martin-Luquero M, Igea R, et al. Effect of quinapril, Quinapril- Hydroclorothiazide, and enalapril on the bone mass of hypertensive subjects: relationship with angiotensin converting enzyme polymorphisms. AJH. 2003;16:453-9.
9. Lynn H, Kwok T, Wong SY, Woo J, Leung PC. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone. 2006;38:584-8.
10. Kirichenko AA, Demel'khanova TS, Riazantsev AA, Novichkova IN, Ebzeeva EI, Iurchenko KV. The use of moexipril in postmenopausal women with hypertension and associated changes of bone mineral density. Kardiologiia. 2005;45:34-7.